Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Unicycive Therapeutics

Tracked across 2 events · 71 articles · First seen Aug 21, 2025 · Last active Sep 22, 2026

Sentiment
-65
Attention
2
Events
2
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 -60
Regulatory
Impact: Unicycive Therapeutics is the subject of a securities investigation following a second FDA Complete Response Letter for its OLC NDA, causing a stock price decline.
Jun 30, 2026 · 13 articles
2 -70
Regulatory
Multiple investor-rights law firms have filed or announced securities fraud class action lawsuits against Unicycive Therapeutics, Inc. (NASDAQ: UNCY) and certain of its officers on behalf of investors who acquired Unicycive securities between December 29,…
Impact: Unicycive is the defendant and central subject of the securities fraud class action, facing allegations of misleading investors about third-party manufacturing deficiencies and the resulting FDA Complete Response Letter for oxylanthanum carbonate. The stock reportedly fell 39.1% on the CRL disclosure, and the litigation adds legal costs and reputational damage.
Sep 03, 2026 · 58 articles
95 Unicycive Therapeutics announced second Complete Response LetterUnicycive Securities Fraud...
ERGEN INTELLIGENCE
Track Unicycive Therapeutics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.